Dual binding mode of a novel series of DHODH inhibitors.
Baumgartner, R., Walloschek, M., Kralik, M., Gotschlich, A., Tasler, S., Mies, J., Leban, J.(2006) J Med Chem 49: 1239-1247
- PubMed: 16480261 
- DOI: 10.1021/jm0506975
- Primary Citation of Related Structures:  
2BXV, 2FPT, 2FPV, 2FPY, 2FQI - PubMed Abstract: 
Human dihydroorotate dehydrogenase (DHODH) represents an important target for the treatment of hyperproliferative and inflammatory diseases. In the cell DHODH catalyzes the rate-limiting step of the de novo pyrimidine biosynthesis. DHODH inhibition results in beneficial immunosuppressant and antiproliferative effects in diseases such as rheumatoid arthritis ...